MONDAY, Feb. 23, 2026 -- People with type 2 diabetes starting semaglutide have more than a doubled risk for nonarteritic anterior ischemic optic...
Vous n'êtes pas connecté
Maroc - NEWS.MEDICAL.NET - A la Une - 12/07/2024 17:05
Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer's disease (AD) were significantly lower in patients treated with metformin and sodium glucose co-transporter-2 inhibitors (SGLT-2i) compared to other antidiabetic drugs.
MONDAY, Feb. 23, 2026 -- People with type 2 diabetes starting semaglutide have more than a doubled risk for nonarteritic anterior ischemic optic...
MONDAY, Feb. 23, 2026 -- People with type 2 diabetes starting semaglutide have more than a doubled risk for nonarteritic anterior ischemic optic...
This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2...
WEDNESDAY, Feb. 18, 2026 -- Cumulative lead exposure is suggested as a potential dementia risk factor, according to a study published online Feb. 12...
WEDNESDAY, Feb. 18, 2026 -- Cumulative lead exposure is suggested as a potential dementia risk factor, according to a study published online Feb. 12...
Welcome to Upstream, The Daily Wire’s new home for for culture and lifestyle. Real human insight and human stories — from our featured writers...
Welcome to Upstream, The Daily Wire’s new home for for culture and lifestyle. Real human insight and human stories — from our featured writers...
Knowing the medications you’re taking and communicating that information to your medical provider is even more important as you get older. As we...
Knowing the medications you’re taking and communicating that information to your medical provider is even more important as you get older. As we...
THURSDAY, Feb. 12, 2026 -- Lifetime exposure to cognitive enrichment is associated with a lower risk for Alzheimer disease (AD) dementia and a slower...